TILS.L Share News (TILS)
TILS Share
TILS Share
TILS Share
TILS Share
TILS
TILS Share
TILS Broker
TILS Directors
TILS Financial
TILS
TILS Short
TILSThu, 18th Jun 2020 18:30
Tiziana Life Sciences PLC - London-based oncology and immunology treatments - Gregor MacRae steps down as director with immediate effect. Says looking for new non-executive director with Nasdaq audit committee experience.
Current stock price: 90.00 pence
Year-to-date change: up more than 100%, 41.00p on January 2
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
(ShareCast News) - Clinical stage biotechnology company Tiziana Life Sciences was celebrating on Wednesday, after its partnership with researchers at Cardiff University collected a fresh award. The AIM-traded company said the partnership, which has led to the development of a potential new drug for
Read more(ShareCast News) - Tiziana Life Sciences has appointed Tiziano Lazzaretti as Chief Financial Officer, effective immediately. Confirming the move on Monday, the AIM-listed biotechnology company said the appointment was not a board level position. Lazzaretti has extensive experience in the healthcare
Read more(ShareCast News) - Tiziana Life Sciences revealed the great strides it had made in the quest for cancer-fighting drugs this week, as part of its research partnership with the Cardiff University / Prifysgol Caerdydd. The AIM-listed biotechnology company, which focuses on targeted drugs to treat disea
Read more